Skip to main content
SpringerLink
Log in

Prostaglandins in inflammatory bone pathology: Mechanism and therapeutic benefit of etodolac

  • Inflammation and Immunomodulation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

To investigate the role of PGE2 in the development of bone and joint pathology in rat adjuvant arthritis, hindlimb paws were evaluated by calcified tissue histologic techniques focusing on histochemical visualization of cartilage and bone lesions. Case studies of hindlimbs from normal, adjuvant arthritic, and etodolac-treated arthritic rats demonstrated the association of disease severity with inflammation, chondromalacia, replacement of adipose bone marrow with a fibroid marrow, osteoclastic bone resorption, synovial cysts, and pannus formation within the joints. Extensive periosteal intramembranous bone formation was temporally associated with joint destruction and medullary tissue pathology.In vivo data were correlated within vitro effects of inflammatory mediators (IL-1, PGE2) on bone resorption. Etodolac blocked bone explant PGE2 accumulation at concentrations of 10−7 M and higher, and inhibited bone resorption at concentrations of 10−5 M and higher. The data indicate thatin vitro andin vivo models of bone metabolism are well correlated regarding prostaglandin synthesis; that the inflammatory mediator PGE2 is largely responsible for the involvement of skeletal tissue in the adjuvant arthritis model; and that the effects of etodolac are specifically mediated by its ability to inhibit PGE2 accumulationin vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. L.G. Raisz and T. J. Martin,Prostaglandins in bone and mineral metabolism. InBone and Mineral Research. Annual 2. (Ed. W. A. Peck) pp. 286–310, Elsevier (1983).

  2. D. C. Klein and L. G. Raisz,Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology86, 1436–1440 (1970).

    PubMed  Google Scholar 

  3. Y. S. Chyun and L. G. Raisz,Stimulation of bone formation by prostaglandin E 2. Prostaglandins27, 97–103 (1984).

    Article  PubMed  Google Scholar 

  4. Y. Hakeda, Y. Nakatani, N. Kurihara, E. Ikeda, N. Maeda and M. Kumegawa,Prostaglandin E 2 stimulates collagen and non-collagen protein synthesis and prolyl hydroxylase activity in osteoblastic clone MC3T3-E1 cells. Biochem. Biophys. Res. Comm126, 340–345 (1985).

    Article  PubMed  Google Scholar 

  5. M. Gowen, D. D. Wood, E. J. Ihrie, M. K. B. McGuire and R. G. G. Russell,An interleukin-1 like factor stimulates bone resorption in vitro. Nature306, 378–380 (1983).

    Article  PubMed  Google Scholar 

  6. K. Sato, Jujii, K. Kasano, M. Saji, T. Tsushima and K. Shizume,Stimulation of prostaglandin E 2 and bone resorption by recombinant human interleukin-1 alpha in fetal mouse bones. Biochem. Biophys Res. Comm.138, 618–624 (1986).

    Article  PubMed  Google Scholar 

  7. M. Gowen and G. R. Mundy,Actions of recombinant interleukin-1, interleukin-2, and interferon-gamma on bone resorption in vitro. J. Immunol.136, 2478–2482 (1986).

    PubMed  Google Scholar 

  8. N. R. Ackerman, W. H. Rooks II, L. Shott, H. Genant, P. Maloney and E. West,Effects of naproxen on connective tissue changes in the adjuvant arthritic rat. Arthritis Rheum.22, 1365–1374 (1979).

    PubMed  Google Scholar 

  9. I. G. Otterness, D. L. Larson and J. G. Lombardino,An analysis of piroxican in rodent models of arthritis. Agents and Actions12, 308–311 (1982).

    PubMed  Google Scholar 

  10. R. R. Martel, J. Klicius and G. Metcalf,Effect of etodolac on articular and bone pathology associated with adjuvent arthritis in rats: a comparison with aspirin and naproxen. Agents and Actions14, 257–264 (1984).

    Article  PubMed  Google Scholar 

  11. B. M. Weichman, T. T. Chau and G. Rona,Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats: evidence for reversal of joint damage. Arthritis Rheum.30, 466–470 (1987).

    PubMed  Google Scholar 

  12. K. D. Rainsford,Adjuvant polyarthritis in rats: is this a satisfactory model for screening anti0arthritic drugs? Agents and Actions12, 453–458 (1982).

    Google Scholar 

  13. J. D. Williams, D. L. Scott, F. B. DeBrito, D. A. Willoughby and E. C. Huskisson,Rheumatoid inflammation and joint destruction: cause and effect of parallel phenomena? Agents and Actions18, 538–543 (1986).

    Article  PubMed  Google Scholar 

  14. R. G. Neuman, B. D. Wilson, M. Barkley, E. S. Kimball, B. M. Weichman and D. D. Wood,Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis. Agents and Actions21, 160–166 (1987).

    PubMed  Google Scholar 

  15. R. Dziak, J. S. Brand,Calcium transport in isolated bone cells. I. Bone cell isolation procedures. J. Cell Physiol.84, 75–84 (1974).

    Article  PubMed  Google Scholar 

  16. G. A. Howard, M. A. Hayward, D. Kowal and D. A. Biondi,Use of a miroplate-reader to quantify osteoblasts and other cells grown in 96-well plates. J. Immunol. Methods, submitted (1988).

  17. SAS User's Guide, SAS Institute, Cary, NC.

  18. H. E. Gruber, G.J. Marshall, M. E. Kirchon, J. Kang and S. G. Massary,Improvements in dehydration and cement line staining for methacryulate embedded human bone biopsis. Stain Technology60, 337–344 (1986).

    Google Scholar 

  19. R. R. Recker,Bone histomorphometry: techniques and interpretation. CRC Press, Boca Raton, FL (1983).

    Google Scholar 

  20. L. Rosenberg,Chemical basis for the histological use of safranin-O in the study of articular cartilage. J. Bone Joint Surg.53 A, 69 (1979).

    Google Scholar 

  21. O. Hoffman, K. Klaushofer, K. Koller and M. Peterlik,Prostaglandin-related bone resorption in cultured neonatal mouse calvaria: evaluation of biopotency of nonsteroidal anti-inflammatory drugs. Prostaglandins30, 857–866 (1985).

    Article  PubMed  Google Scholar 

  22. B. M. Thomson, J. Saklatvala and T. J. Chambers,Osteoblasts mediate interleukin-1 stimulation of bone resorption by rat osteoclasts. J. Exp. Med.164, 104–112 (1984).

    Article  Google Scholar 

  23. H. Skjodt, A. Crawford, P. R. Elsford, E. Ihrie, D. D. Wood and R. G. G. Russell,Cyclosporin A modulates interleukin-1 activity on bone in vitro. Br. J. Rheum.24, Suppl. 1, 165–169 (1985).

    Google Scholar 

  24. C. E. Brinckerhoff, P. W. Coffey and A. C. Sullivan,Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis retinoic acid. Science221, 755–758 (1983).

    Google Scholar 

  25. D. A. Lowther, J. D. Sandy, V. B. Santer and H. L. G. Brown,Antigen-induced arthritis: decreased proteoglycan content and inhibition of proteoglycan synthesis in articular cartilage. Arthritis Rheum.21, 675–680 (1978).

    PubMed  Google Scholar 

  26. J. D. Dandy, D. A. Lowther and H. L. G. Brown,Antigen-induced arthritis: studies on the inhibition of proteoglycan synthesis observed in articular cartilage during short-term joint inflammation. Arthritis Rheum.23, 433–447 (1980).

    PubMed  Google Scholar 

  27. M. W. M. Kruigsen, W. B. van den Berg, L. B. A. van de Putte,Influence of the severity and duration of murine antigen induced arthritis on cartilage proteoglycan synthesis and chondrocyte death. Arthritis Rheum.28, 813–819 (1985).

    PubMed  Google Scholar 

  28. W. S. S. Jee, K. Ueno, D. B. Kimmel, D. M. Woodbury, P. Price, and L. A. Woodbury,The role of bone cells in increaseasing metaphyseal hard tissue in rapidly growing rats trated with prostaglandin E 2. Bone8, 171–178 (1987).

    Article  PubMed  Google Scholar 

  29. K. Tomoda, M. Kitaoka, K.-I. Iyama and G. Usuku,Endosteal new bone formation in the long bones of adjuvant trated rats. Path. Res. Pract.181, 331–338 (1986).

    PubMed  Google Scholar 

  30. R. C. Williams, M. K. Jeffcoat, M. L. Kaplan, P. Goldhaber, H. G. Johnson and W. J. Wechter,Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science227, 640–642 (1985).

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. M. A. Hayward

    Present address: Johnson and Johnson Health Care Company, 501 George St., 08903, New Brunswick, NJ, USA

Authors and Affiliations

  1. Wyeth-Ayerst Research, NC 8000, 08543, Princeton, NJ

    M. A. Hayward & B. M. Weichman

  2. Anatomy, Purdue University, 47907, W. Lafayette, IN

    D. C. Van Sickle

  3. American Lake V. A. Medical Center, 98493, Tacoma, WA

    G. A. Howard

  4. Exocell, Inc., 3508 Market St., 19104, Philadelphia, PA

    R. G. Neuman

  5. Miles Inc., 400 Morgan Lane, 06516, W. Haven, CT, USA

    D. D. Wood

Authors
  1. M. A. Hayward
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. A. Howard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. G. Neuman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. D. Wood
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. M. Weichman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. C. Van Sickle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayward, M.A., Howard, G.A., Neuman, R.G. et al. Prostaglandins in inflammatory bone pathology: Mechanism and therapeutic benefit of etodolac. Agents and Actions 26, 310–318 (1989). https://doi.org/10.1007/BF01967295

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967295

Keywords

Search

Navigation